Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThg Regulatory News (THG)

Share Price Information for Thg (THG)

Share Price is delayed by 15 minutes
Get Live Data
31.72    -0.18 (-0.56%)
Bid:
31.76
Ask:
31.98
Spread: 0.22 (0.693%)
Market Cap: £503.35m
THG Live PriceLast checked at - London Stock Exchange

Intraday Thg Share Chart

Completion of debt refinancing

4 Apr 2025 07:00

RNS Number : 6285D
THG PLC
04 April 2025
 

04 April 2025

 

THG PLC

 

Successful completion of debt refinancing to December 2029

 

 

THG PLC ("THG" or the "Company") today announces the successful completion of its debt refinancing to 2029.

 

As noted on 24 March 2025, THG has been undertaking a comprehensive refinancing exercise. To confirm, this includes:

 

· a partial Amend & Extend of the Term Loan B to extend the maturity of €445m to December 2029;

· a partial repayment of £74m of the Term Loan A and the remaining €155m of the TLB through a combination of cash on balance sheet and the Equity Contribution; and

· extending the maturity of the existing £150m RCF from May 2026 to May 2029.

 

As a result of the proposed refinancing, net total leverage (excl. leases) decreases from 3.2x to 2.2x pre deal fees based on FY 2024 continuing Adjusted EBITDA (excluding Ingenuity) of £92m. THG is a fundamentally cash generative business and the refinancing underlines the Company's target to progress towards a neutral net cash / net debt position.

 

J.P. Morgan and Barclays acted as Mandated Lead Arrangers and Physical Bookrunners on the debt refinancing, with HSBC Bank plc, NatWest Markets PLC and BNP Paribas S.A. as Joint Bookrunners. Clifford Chance LLP acted on behalf of the Company, with Latham & Watkins (London) LLP acting for the lenders.

 

More details of FY 2024 performance will be provided as part of the Group's preliminary results and Q1 trading update expected to be announced on or around 30 April.

 

 

For further information, please contact:

Investor enquiries - THG PLC

 

Kate Grimoldby, Director of Investor Relations and Strategic Projects

Investor.Relations@thg.com

 

Media enquiries:

Sodali & Co - Financial PR adviser

Tel: +44 (0) 20 7250 1446

Victoria Palmer-Moore / Russ Lynch

thg@sodali.com

 

 

THG PLC

 

media-enquiries@thg.com

 

 

 

Notes to editors

 

THG PLC is a global e-commerce group headquartered in Manchester, UK, operating through two leading consumer businesses: THG Beauty and THG Nutrition.

 

THG Beauty operates prominent online platforms including Lookfantastic, Dermstore and Cult Beauty, offering a valued route to market for over 1,300 third-party brands, alongside a specialist portfolio of owned brands.

 

THG Nutrition, led by Myprotein, the world's largest online sports nutrition brand, spans multiple health and wellness categories, delivering its products both directly to consumers and through strategic offline partnerships worldwide. 

 

 

Cautionary Statement

 

Certain statements included within this announcement may constitute "forward-looking statements" in respect of the group's operations, performance, prospects and/or financial condition. Forward-looking statements are sometimes, but not always, identified by their use of a date in the future or such words and words of similar meaning as "anticipates", "aims", "due", "could", "may", "will", "should", "expects", "believes", "intends", "plans", "potential", "targets", "goal" or "estimates". By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions and actual results or events may differ materially from those expressed or implied by those statements. Accordingly, no assurance can be given that any particular expectation will be met and reliance should not be placed on any forward-looking statement. Additionally, forward-looking statements regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. No responsibility or obligation is accepted to update or revise any forward-looking statement resulting from new information, future events or otherwise. Nothing in this announcement should be construed as a profit forecast. This announcement does not constitute or form part of any offer or invitation to sell, or any solicitation of any offer to purchase any shares or other securities in the Company, nor shall it or any part of it or the fact of its distribution form the basis of, or be relied on in connection with, any contract or commitment or investment decisions relating thereto, nor does it constitute a recommendation regarding the shares or other securities of the Company. Past performance cannot be relied upon as a guide to future performance and persons needing advice should consult an independent financial adviser. Statements in this announcement reflect the knowledge and information available at the time of its preparation.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCZZGGDZFNGKZZ
Date   Source Headline
17th Sep 20247:01 amRNSInterim results
17th Sep 20247:00 amRNSESCC transfer & Ingenuity demerger update
12th Sep 202411:52 amRNSNotice of Results
2nd Sep 20247:00 amRNSTotal Voting Rights
1st Aug 20243:48 pmRNSGrant of Share Options
1st Aug 20247:00 amRNSTotal Voting Rights
1st Jul 20247:00 amRNSTotal Voting Rights
24th Jun 20243:35 pmRNSResult of AGM
24th Jun 20247:00 amRNSAGM trading update and Frasers Group partnership
3rd Jun 20247:00 amRNSTotal Voting Rights
17th May 20247:00 amRNSNotice of AGM
10th May 202412:36 pmRNSDirector/PDMR Shareholding
1st May 20247:01 amRNSBlock Listing Six Monthly Return
1st May 20247:00 amRNSTotal Voting Rights
29th Apr 20247:00 amRNSAnnual Report & Accounts 2023
26th Apr 202410:31 amRNSDirector/PDMR Shareholding
23rd Apr 20247:00 amRNSQ1 2024 Trading Statement
22nd Apr 20244:31 pmRNSNotice of Q1 Trading Update
10th Apr 20247:00 amRNSPreliminary FY 2023 results
2nd Apr 20247:00 amRNSTotal Voting Rights
15th Mar 20247:00 amRNSDirectorate Change
13th Mar 20247:00 amRNSApplication for Listing and Total Voting Rights
7th Mar 20244:15 pmRNSGrant of Share Options
4th Mar 20247:00 amRNSRevolving Credit Facility extension to May 2026
1st Mar 20247:00 amRNSTotal Voting Rights
1st Feb 20247:00 amRNSTotal Voting Rights
16th Jan 20247:01 amRNSQ4 Trading Statement
16th Jan 20247:00 amRNSIngenuity fulfilment partnership
2nd Jan 20247:00 amRNSTVR & 2023 AGM Voting Outcome Update
5th Dec 20237:00 amRNSAcquisition of Biossance
4th Dec 20237:00 amRNSTotal Voting Rights
1st Nov 20237:01 amRNSBlock Listing Six Monthly Returns
1st Nov 20237:00 amRNSTotal Voting Rights
17th Oct 20237:00 amRNSQ3 2023 Trading Statement
2nd Oct 20237:00 amRNSTotal Voting Rights
14th Sep 20237:00 amRNSInterim results for the half-year ended 30 June 23
1st Sep 20237:00 amRNSNotice of Results
1st Aug 20237:00 amRNSTotal Voting Rights
21st Jul 20237:00 amRNSStrategic review update
3rd Jul 20237:00 amRNSTotal Voting Rights
23rd Jun 20237:00 amRNSPDMR-PCA Shareholdings
23rd Jun 20237:00 amRNSPDMR / PCA Shareholdings
22nd Jun 202311:31 amRNSPDMR/PCA Shareholdings
21st Jun 20232:55 pmRNSResult of AGM
21st Jun 20237:01 amRNSChanges to Board Composition
21st Jun 20237:00 amRNSAGM Trading Statement
18th May 20234:00 pmRNSNotice of AGM
18th May 20238:35 amRNSForm 8.5 (EPT/NON-RI) THG PLC Amendment
18th May 20238:33 amRNSForm 8.5 (EPT/NON-RI) THG PLC Amendment
17th May 20237:16 amRNSForm 8.5 (EPT/NON-RI) THG PLC amendment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.